• Cellectis Announces Collaboration Agreement With AstraZeneca; To Receive Up To $245 Mln

    Source: NASDAQ US Markets / 01 Nov 2023 05:05:04   America/New_York

    (RTTNews) - Cellectis (CLLS) has entered into a Joint Research Collaboration Agreement, an investment agreement relating to an initial equity investment of $80 million, and a MOU relating to an additional equity investment of $140 million, with AstraZeneca. Cellectis will receive https://www.nasdaq.com/articles/cellectis-announces-collaboration-agreement-with-astrazeneca-to-receive-up-to-$245-mln
Share on,